Annexin appoints Dr. Alain Thibault as Therapeutic Area Head of Oncology.
STOCKHOLM January 18, 2023 Annexin Pharmaceuticals AB (publ) announces that Dr. Thibault, a medical oncologist with extensive global experience leading novel compounds through clinical development, will join as a new team member and Therapy Area Head, Oncology. Dr Thibault obtained his Medical Degree at McGill University Montreal, Canada and Board Certification in Oncology and Internal Medicine in the US. He has held management and specialist positions at Roche, J&J and Regeneron as well as Chief Medical Officer roles in biotech companies. “Annexin is now entering the field